Viewing nowCombinationEmpamax M Tablet 12.5/500 mg (Empagliflozin, Metformin)
Empagliflozin L-Proline 15.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Jonggeun Dang Co., Ltd.

MFDS item code 202107452 · Approved 2021.11.12 · Insurance code 643309940
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus by combining empagliflozin and metformin. The effect of this medication on the occurrence of cardiovascular events can be obtained from clinical trial information for experts in patients with type 2 diabetes who have inadequate glycemic control and cardiovascular diseases. Therefore, this medication assists in the improvement of glycemic control and disease management in patients with type 2 diabetes.
The recommended dose of this medicine is 1 tablet twice daily. Determine the dose based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who cannot achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose when taking this medicine is empagliflozin 5 mg twice daily (total daily dose 10 mg) plus the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their previous doses of empagliflozin and metformin. When this medicine is administered concomitantly with a sulfonylurea or insulin, a dose reduction of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take twice the dose at one time; skip the missed dose in that case. No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or CrCl of 45-59 ml/min who have no other condition that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, discontinue this medicine immediately (see Precautions for Use, 2. Patients in Whom This Medicine Is Contraindicated, item 2)). In patients aged 75 years or older, consider renal function and the risk of volume depletion.
This medication can cause rare side effects such as severe lactic acidosis, so if symptoms of lactic acidosis appear, immediate consultation with a physician is necessary. Be cautious as hypoglycemia may occur when taken with other diabetes medications. This medication should not be taken by patients with moderate or severe renal impairment. Patients with acute conditions such as acute renal failure, severe infections, or cardiovascular diseases should not be administered this drug. It is safest for pregnant or breastfeeding women to avoid this medication. If surgery is planned or examinations involving iodinated contrast agents are to be conducted, this medication should be discontinued for a certain period. Elderly patients or those with reduced renal function should undergo regular kidney function tests and dosage adjustments may be necessary as required. This medication can increase the risk of urinary tract infections and genital infections, so if related symptoms occur, you should immediately inform a healthcare provider. Alcohol consumption can increase the risk of side effects with this medication, so it's advisable to avoid it while taking this drug. As hypoglycemic symptoms may appear, blood glucose levels should be closely monitored, especially when used in combination with insulin or sulfonylureas. If there are symptoms of fluid loss or dehydration, this medication may be temporarily discontinued; thus, fluid status should be periodically monitored. There is a risk of vitamin B12 deficiency, so it is recommended to regularly check B12 levels during prolonged use. If any unusual symptoms such as fever, genital pain, swelling, rashes occur while taking this medication, immediate consultation with a healthcare provider is advised.
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly closed container to prevent exposure to air or moisture and should be kept at room temperature between 1 to 30 degrees Celsius. Therefore, avoid direct sunlight and do not store it in excessively hot or cold places.
Light brownish-purplish, oval, biconvex film-coated tablet
60 tablets/box [10 tablets/PTP x 6], 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEmpagliflozin L-Proline 15.7mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Jonggeun Dang Co., Ltd.
CombinationEmpagliflozin L-Proline 15.7mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationEmpagliflozin L-Proline 15.7mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
(Co., Ltd.) Chong Kun Dang
CombinationEmpagliflozin L-Proline 6.28mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationEmpagliflozin L-Proline 6.28mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationEmpagliflozin L-Proline 6.28mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationEmpagliflozin L-Proline 12.55mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
CombinationEmpagliflozin L-Proline 31.38mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.